Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Behavior Research Methods|February 10, 2022
Applying multiverse analysis to experience sampling data: Investigating whether preprocessing choices affect robustness of conclusionsJeroen Weermeijer, Ginette Lafit, Glenn Kiekens, et al.
International Clinical Psychopharmacology|December 13, 2006
Pharmacological treatment of severe dyslipidaemia in patients with schizophreniaLinda Hanssens, Marc De Hert, Dita Kalnicka, et al.
The Journal of Clinical Psychiatry|December 30, 2006
Treatment with rosuvastatin for severe dyslipidemia in patients with schizophrenia and schizoaffective disorderMarc De Hert, Dita Kalnicka, Ruud van Winkel, et al.
Plos One|September 13, 2019
Which clinical and biochemical predictors should be used to screen for diabetes in patients with serious mental illness receiving antipsychotic medication? A large observational studyAlex J Mitchell, Davy Vancampfort, Peter Manu, et al.
JMIR Formative Research|November 21, 2023
Usability of the Experience Sampling Method in Specialized Mental Health Care: Pilot Evaluation StudyJeroen Dennis Merlijn Weermeijer, Martien Wampers, Lena de Thurah, et al.
Schizophrenia Research|December 13, 2012
Insulin secretion in patients receiving clozapine, olanzapine, quetiapine and risperidonePeter Manu, Christoph U Correll, Martien Wampers, et al.
The Journal of Clinical Psychiatry|August 7, 2008
Psychiatric diagnosis as an independent risk factor for metabolic disturbances: results from a comprehensive, naturalistic screening programRuud van Winkel, Jim van Os, Ivan Celic, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|September 27, 2015
Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysisDavy Vancampfort, Brendon Stubbs, Alex J Mitchell, et al.
Schizophrenia Research|August 3, 2010
Effects of cannabis use on age at onset in schizophrenia and bipolar disorderMarc De Hert, Martien Wampers, Tihana Jendricko, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 23, 2011
Differential effects of olanzapine and risperidone on plasma adiponectin levels over time: results from a 3-month prospective open-label studyMartien Wampers, Linda Hanssens, Ruud van Winkel, et al.
Pageof 6